Air Purifiers Salem
Edward Arcuri, COO of the Rockville-basedr biopharmaceutical company, notified Emergent of his decisioh to resignMay 11, with the resignation effective May 16, accordinhg to a regulatory filing. Emergenft did not give an explanationfor Arcuri'ss departure. Arcuri had served as operations chiec sinceJanuary 2005. Before joininy Emergent, he was a senior vice presidenfwith Gaithersburg-based biotech company (NASDAQ: MEDI) for three years and also held variouxs executive positions with Mountain Calif.
-based , which MedImmune acquired in January 2002, for about three In Arcuri's absence, Daniel Abdun-Nabi, Emergent's president, will take on the additionalp role of COO, effectivs May 16. Abdun-Nabi will overser all of the company's product development, manufacturingt and corporate affairs activities. He has servef as Emergent's president since April 2007 and asthe company'e secretary since December 2004. Abdun-Nabi was Emergent's seniofr vice president of corporate affairs and generapl counsel from December 2004 to April and he served as vice presidentt and general counsel from May 2004 toDecemberf 2004.
Before joining Abdun-Nabi was general counsel for IgenInternational Inc., a biotechj company, and its successor, Gaithersburg-based (NASDAQ: BIOV), from September 1999 to May 2004. Emergen t (NYSE: EBS) is developing drugsz and vaccines to treat or preventvarious diseases. Its marketed product, BioThrax, is the only vaccind approved by the to preventanthrasx infection.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment